{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Juvenile dermatomyositis",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_azathioprine",
          "name": "Azathioprine"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_prednisone",
          "name": "Prednisone"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_mycophenolate_mofetil",
          "name": "Mycophenolate mofetil"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_ivig",
          "name": "IVIG"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_tacrolimus",
          "name": "Tacrolimus"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_dexamethasone",
          "name": "Dexamethasone"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_hydroxychloroquine",
          "name": "Hydroxychloroquine"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_natalizumab",
          "name": "Natalizumab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_etanercept",
          "name": "Etanercept"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_prednisone",
          "type": "Drug",
          "label": "Prednisone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mycophenolate_mofetil",
          "type": "Drug",
          "label": "Mycophenolate mofetil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ivig",
          "type": "Drug",
          "label": "IVIG",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tacrolimus",
          "type": "Drug",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dexamethasone",
          "type": "Drug",
          "label": "Dexamethasone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_hydroxychloroquine",
          "type": "Drug",
          "label": "Hydroxychloroquine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_natalizumab",
          "type": "Drug",
          "label": "Natalizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "juvenile_dermatomyositis",
          "type": "Disease",
          "label": "Juvenile dermatomyositis",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_methotrexate",
          "target": "juvenile_dermatomyositis",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Methotrexate is commonly used for juvenile dermatomyositis."
        },
        {
          "source": "drug_azathioprine",
          "target": "juvenile_dermatomyositis",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Azathioprine is indicated for autoimmune conditions."
        },
        {
          "source": "drug_prednisone",
          "target": "juvenile_dermatomyositis",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Glucocorticoids are a mainstay in inflammatory myopathies."
        },
        {
          "source": "drug_mycophenolate_mofetil",
          "target": "juvenile_dermatomyositis",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Mycophenolate mofetil has immunosuppressive effects."
        },
        {
          "source": "drug_ivig",
          "target": "juvenile_dermatomyositis",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "IVIG shows efficacy in autoimmune myopathies."
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "juvenile_dermatomyositis",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Cyclophosphamide may be used in severe cases."
        },
        {
          "source": "drug_rituximab",
          "target": "juvenile_dermatomyositis",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Rituximab has shown promise in refractory cases."
        },
        {
          "source": "drug_tacrolimus",
          "target": "juvenile_dermatomyositis",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "Tacrolimus can be used as an alternative immunosuppressant."
        },
        {
          "source": "drug_dexamethasone",
          "target": "juvenile_dermatomyositis",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Dexamethasone is a potent corticosteroid."
        },
        {
          "source": "drug_hydroxychloroquine",
          "target": "juvenile_dermatomyositis",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "Hydroxychloroquine is used for autoimmune diseases."
        },
        {
          "source": "drug_natalizumab",
          "target": "juvenile_dermatomyositis",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "Natalizumab targets specific immune pathways."
        },
        {
          "source": "drug_etanercept",
          "target": "juvenile_dermatomyositis",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "Etanercept is involved in inflammatory pathways."
        }
      ]
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物可针对青少年皮肌炎，其中包括免疫抑制剂和生物制剂。",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "药物的给药方案和患者对药物的反应因个体差异而异。"
    ],
    "uncertainties": [
      "某些药物在青少年皮肌炎的使用数据较少，需后续研究确认。"
    ],
    "next_focus_for_pi": [
      "是否需补充对每种药物作用机制的详细评估及长期疗效的研究？"
    ]
  }
}